The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.
about
UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.SERP1 is a novel marker of poor prognosis in pancreatic ductal adenocarcinoma patients via anti-apoptosis and regulating SRPRB/NF-κB axisClinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients.New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review
P2860
The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Role of BRCA2 Mutation Sta ...... omarker for Pancreatic Cancer.
@en
The Role of BRCA2 Mutation Sta ...... omarker for Pancreatic Cancer.
@nl
type
label
The Role of BRCA2 Mutation Sta ...... omarker for Pancreatic Cancer.
@en
The Role of BRCA2 Mutation Sta ...... omarker for Pancreatic Cancer.
@nl
prefLabel
The Role of BRCA2 Mutation Sta ...... omarker for Pancreatic Cancer.
@en
The Role of BRCA2 Mutation Sta ...... omarker for Pancreatic Cancer.
@nl
P2860
P921
P356
P1476
The Role of BRCA2 Mutation Sta ...... omarker for Pancreatic Cancer.
@en
P2093
Jesus Garcia-Foncillas
P2860
P304
P356
10.1155/2016/1869304
P407
P577
2016-12-18T00:00:00Z